Current opinions on safer red cell transfusion practice and the appropriate use of alternative strategies

Transfusion and Apheresis Science

Volumn 37, Issue 2, 2007, Pages 201-207

  Seghatchian, Jerard ^a   Solheim, Bjarte G ^b  

^a Blood Components/Apheresis Technology and Haemostasis/Thrombosis Consultancy   (United Kingdom)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; APROTININ; ERYTHROPOIETIN; FERUMOXYTOL; GERMALL 115; IRON; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; POLYMERIZED HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; APHERESIS; ARTICLE; BLEEDING; BLOOD BANK; BLOOD COMPONENT; BLOOD DONOR; BLOOD SALVAGE; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CONTINUING EDUCATION; COST BENEFIT ANALYSIS; DEEP VEIN THROMBOSIS; ERYTHROCYTE TRANSFUSION; GAMMA IRRADIATION; HEMATOCRIT; HEMODILUTION; HEMOGLOBIN DETERMINATION; HUMAN; MULTIPLE MYELOMA; POLYCYTHEMIA;

EID: 36549051172     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2007.09.001     Document Type: Note

References (0)